1-3 of 3
Lanlan Shen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Limited Effect of TET2 Mutations on Promoter DNA Methylation in Chronic Myelomonocytic Leukemia

Jumpei Yamazaki, DVM, PhD, Rodolphe F Taby, MD, Aparna Vasanthakumar, PhD, Trisha Macrae, Kelly R Ostler, BA, Lanlan Shen, MD, PhD, Hagop M. Kantarjian, Marcos R Estecio, PhD, Jaroslav Jelinek, MD, PhD, Lucy Godley, MD, PhD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2011) 118 (21): 1365.
https://doi.org/10.1182/blood.V118.21.1365.1365
Published: 2011
Journal Articles

Aberrant DNA Methylation in CML Is Associated with Disease Progression and Resistance to Imatinib Mesylate.

Jaroslav Jelinek, MD, PhD, Vazganush Gharibyan, Yasuhiro Oki, MD, Woonbok Chung, PhD, Lanlan Shen, MD PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Jean-Pierre J. Issa, MD
Journal: Blood
Blood (2006) 108 (11): 2192.
https://doi.org/10.1182/blood.V108.11.2192.2192
Published: 2006
Journal Articles

CpG Island Methylation Is a Poor Prognostic Factors in Myelodysplastic Syndrome Patients and Is Reversed by Decitabine Therapy-Results of a Phase III Randomized Study.

Lanlan Shen, MD, PhD, Hagop Kantarjian, MD, Hussain Saba, MD, E. Lin, Don Berry, Saira Ahmed, Jaroslav Jelinek, MD, Jean-Pierre J. Issa, MD
Journal: Blood
Blood (2005) 106 (11): 790.
https://doi.org/10.1182/blood.V106.11.790.790
Published: 2005